Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Unknown × Hydatidiform Mole × Clear all

Phase

Phase 4 1 Phase 3 1 Phase 2/3 1

Status

Completed 3 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 124 Carcinoma, Non-Small-Cell Lung 88 Colorectal Neoplasms 81 Carcinoma, Hepatocellular 65 Stomach Neoplasms 60 Rectal Neoplasms 48 Neoplasms 46 Lung Neoplasms 40 Nasopharyngeal Carcinoma 37 Leukemia, Myeloid, Acute 37 Lymphoma, Large B-Cell, Diffuse 36 Colonic Neoplasms 36 Prostatic Neoplasms 33 Neoplasm Metastasis 33 Uterine Cervical Neoplasms 30 Multiple Myeloma 29 Lymphoma, Follicular 29 Esophageal Neoplasms 29 Ovarian Neoplasms 27 Lymphoma 27 Pancreatic Neoplasms 26 Leukemia 26 Recurrence 21 Brain Neoplasms 19 Lymphoma, Non-Hodgkin 18 Urinary Bladder Neoplasms 17 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Head and Neck Neoplasms 17 Lymphoma, Mantle-Cell 16 Leukemia, Lymphocytic, Chronic, B-Cell 16

Interventions

Vacuum Curettage 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04756713 2022-05-27

ReCure

Brigham and Women's Hospital

Phase 3 Unknown

Hydatidiform Mole, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡